版本:
中国

BRIEF-Windtree Therapeutics says presented Aerosurf Phase 2A data

Nov 28 Windtree Therapeutics Inc

* Windtree Therapeutics' Aerosurf (lucinactant for inhalation) phase 2A data presented at the 2016 International Congress of Union of European Neonatal and Perinatal Societies Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐